Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

STI571 in Treating Patients With Recurrent Leukemia

NCT00004932

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 235 locations
View Trial Details
Completed

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00083070

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Completed

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

NCT00066248

Conditions
Astrocytoma, Blast Crisis, Body Weight, +83 more
Locations
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
View all 43 locations
View Trial Details
Completed

Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

NCT00896129

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy
  • Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy
  • Nuovo ospedale "Torrette" Ancona, Italy
  • Unità Operativa Ematologica - Università degli Studi di Bari Bari, Italy
View all 25 locations
View Trial Details

Related conditions